Management of liver disease and portal hypertension in cystic fibrosis: a review
Author:
Affiliation:
1. Cystic Fibrosis Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
2. Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.1080/17476348.2024.2365842
Reference111 articles.
1. Liver involvement in cystic fibrosis: primary organ damage or innocent bystander?
2. Cystic Fibrosis Foundation Patient Registry. 2022 Annual Data Report. Cystic Fibrosis Foundation Publications; 2022 [Online]. Available from: https://www.idtheftcenter.org/post/identity-theft-resource-center-2021-annual-data-breach-report-sets-new-record-for-number-of-compromises/
3. Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy
4. Cystic Fibrosis–related Liver Disease: Research Challenges and Future Perspectives
5. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3